Skip to main content
. 2021 Jun 23;12(7):642. doi: 10.1038/s41419-021-03930-2

Fig. 6. PI3K/Akt pathway mediated high glucose-induced DNMT1, DNMT3a, and TXNIP upregulation in RSC96 cells.

Fig. 6

A Western blot of phospho-Akt (Ser 473), phospho-Akt (Thr 308), and Akt and statistical analysis in RSC96 cells treated with normal glucose, high glucose and mannitol. *P < 0.05 versus N group. B Western blot and statistical analysis of DNMT1, DNMT3a, and TXNIP in RSC96 cells treated with LY294002. *P < 0.05 versus DMSO group. C Immunofluorescence of TXNIP in RSC96 cells treated with LY294002. The inset was shown with dashed square. White arrows showed positive staining. Bar: 20 μm. D Immunofluorescence of DNMT1 in RSC96 cells treated with LY294002. The inset was shown with dashed square. White arrows showed the positive staining. Bar: 20 μm. E Immunofluorescence of DNMT3a in RSC96 cells treated with LY294002. The inset was shown with dashed square. White arrows showed the positive staining. Bar: 20 μm. F Western blot and statistical analysis of the time-dependent effect of LY294002 on DNMT1, DNMT3a, and TXNIP in high glucose-cultured RSC96 cells. *P < 0.05 versus 1 h group. G Western blot and statistical analysis of the effect of insulin on DNMT1, DNMT3a, and TXNIP in RSC96 cells. *P < 0.05 versus N group, # means P < 0.05 versus H group. H Immunofluorescence of TXNIP expression in high glucose cultured RSC96 cells treated with insulin. The inset was shown with dashed square. White arrows showed the positive staining. Bar: 20 μm. I Western blot of the effect of DNMT1 and DNMT3a knockdown on TXNIP expression in LY294002-treated RSC96 cells. *P < 0.05 versus N group, #P < 0.05 versus NC group.